MILELLA, MICHELE STANISLAW

MILELLA, MICHELE STANISLAW  

Mostra prodotti
Risultati 1 - 20 di 51 (tempo di esecuzione: 0.044 secondi).
Titolo Data di pubblicazione Autore(i) File
176. Viper envenomation with ocular neurotocic effects managed without antidote admiistration:a case report 39th International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 21-24 May 2019, Naples, Italy 2019 Milella, MICHELE STANISLAW; M signoretti, Susanna; Lanni, Emanuela; Grassi, Maria Caterina
A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer 2009 Bria, E.; Milella, M.; Sperduti, I.; Alessandrini, G.; Visca, P.; Corzani, F.; Giannarelli, D.; Cerasoli, Virna; Cuppone, F.; Cecere, F. L.; Marchetti, A.; Sacco, R.; Mucilli, F.; Malatesta, S.; Guetti, Leonardo; Vitale, L.; Ceribelli, A.; Rinaldi, M.; Terzoli, E.; Cognetti, F.; Facciolo, F.
Accidental ingestion of nicotine solution for e-cigarettes: a case report 2017 Milella, MICHELE STANISLAW; Ialongo, Cristiano; Susanna M., Signoretti; Grassi, Maria Caterina
Adjuvant treatment for resected renal cell carcinoma. Are all strategies equally negative? Potential implications for trial design with targeted agents 2013 Massari, F.; Bria, E.; Maines, F.; Milella, M.; Giannarelli, D.; Cognetti, F.; Pappagallo, Gianpiero; Tortora, G.; Porta, C.
An outbreak of foodborne botulism in Rome 2018 Milella, Michele S.; Signoretti, Susanna M.; Bagella, FRANCESCO MARIA; Fabrizio, Anniballi; Bruna, Auricchio; Lonati, Davide; Grassi, Maria Caterina
Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers 2009 Pino, M. S.; Milella, M.; Gelibter, A.; Sperduti, I.; De Marco, S.; Nuzzo, C.; Bria, E.; Carpanese, Livio; Ruggeri, E. M.; Carlini, P.; Cognetti, F.
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors. an important role for mutations in minor clones 2009 Marchetti, Antonio; Milella, Michele; Felicioni, Lara; Cappuzzo, Federico; Irtelli, Luciana; Del Grammastro, Maela; Sciarrotta, Mariagrazia; Malatesta, Sara; Nuzzo, Carmen; Finocchiaro, Giovanna; Perrucci, Bruno; Carlone, Donatella; Gelibter, Alain J; Ceribelli, Anna; Mezzetti, Andrea; Iacobelli, Stefano; Cognetti, Francesco; Buttitta, Fiamma
Clinical significance of PTEN and p-Akt co-expression in HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies 2010 Fabi, A.; Metro, G.; Di Benedetto, A.; Nistico, C.; Vici, P.; Melucci, E.; Antoniani, B.; Perracchio, L.; Sperduti, I.; Milella, M.; Cognetti, F.; Mottolese, M.
Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior. 2011 DE CAROLIS, Lorenza; Chiara, Schepisi; Milella, MICHELE STANISLAW; Nencini, Paolo
Compulsive-like effects of quinpirole on drinking behavior in rats are inhibited by substituting ethanol for water 2007 Davide, Amato; Milella, MICHELE STANISLAW; Badiani, Aldo; Nencini, Paolo
Compulsive-like effects of repeated administration of quinpirole on drinking behavior in rats 2006 Davide, Amato; Milella, MICHELE STANISLAW; Badiani, Aldo; Nencini, Paolo
Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer? Meta-analysis of randomized trials 2009 Bria, E.; Cuppone, Francesca; Giannarelli, D.; Milella, M.; Ruggeri, E. M.; Sperduti, I.; Pinnaro, P.; Terzoli, E.; Cognetti, F.; Carlini, P.
E-learning course improves knowledge in tobacco dependence, electronic nicotine delivery systems and heat-not-burn products in Medical School students 2021 Milella, M. S.; Sansone, A.; Basili, S.; Battaglia, G.; la Torre, G.; Ferketich, A. K.; Grassi, M. C.
Early recurrence risk: Aromatase inhibitors versus tamoxifen 2010 Bria, E.; Carlini, P.; Cuppone, F.; Vaccaro, V.; Milella, M.; Cognetti, F.
EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy 2012 Milella, M.; Nuzzo, C.; Bria, E.; Sperduti, I.; Visca, P.; Buttitta, F.; Antoniani, B.; Merola, R.; Gelibter, A.; Cuppone, F.; D'Alicandro, V.; Ceribelli, A.; Rinaldi, M.; Cianciulli, A.; Felicioni, L.; Malatesta, S.; Marchetti, A.; Mottolese, Marcella.; Cognetti, F.
Emerging pathways and future targets for the molecular therapy of pancreatic cancer 2011 Vaccaro, V.; Melisi, D.; Bria, E.; Cuppone, F.; Ciuffreda, L.; Pino, M. S.; Gelibter, A.; Tortora, G.; Cognetti, F.; Milella, M.
Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study 2017 Archibugi, L; Piciucchi, M; Stigliano, S; Zerboni, G; Barucca, V; Milella, M; Maisonneuve, P; Delle Fave, G; Capurso, G.
First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer 2013 Vaccaro, V.; Bria, E.; Sperduti, I.; Gelibter, A.; Moscetti, L.; Mansueto, G.; Ruggeri, E. M.; Gamucci, T.; Cognetti, F.; Milella, M.
Fixed-dose-rate gemcitabine. A viable first-line treatment option for advanced pancreatic and biliary tract cancer 2010 Milella, M.; Gelibter, A. J.; Pino, MARIA SIMONA; Bossone, G.; Marolla, P.; Sperduti, I.; Cognetti, F.
Heroin and its metabolites: relevance to heroin use disorder 2023 Milella, MICHELE STANISLAW; D’Ottavio, Ginevra; DE PIRRO, Silvana; Barra, Massimo; Caprioli, Daniele; Badiani, Aldo